VOTIS Subdermal Imaging Technologies: Funding & Investors (Sep 2026)
VOTIS Subdermal Imaging Technologies help diabetics keep their feet through early screening for peripheral vascular disease and related complications. Early screening can offer new treatment options and help reduce incidents of amputation. Their device is non-invasive and contact-free, not based on radiation, and functionally consistent with the guidelines of the AHA, the American Diabetes Association, and other leading medical organizations. It will reduce healthcare costs for hospitals, clinics, and insurers.
VOTIS Subdermal Imaging Technologies has raised $2.5M across 1 funding round on record, the most recent an undisclosed round of $2.5M announced in Jun 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VOTIS Subdermal Imaging Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2021.
VOTIS Subdermal Imaging Technologies Funding Rounds
VOTIS Subdermal Imaging Technologies Founders and Leadership Team
No contact details are on record for this team yet.
VOTIS Subdermal Imaging Technologies Funding Compared to Other Biotechnology Startups
VOTIS Subdermal Imaging Technologies' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VOTIS Subdermal Imaging Technologies in Biotechnology and Jerusalem
Companies Similar to VOTIS Subdermal Imaging Technologies
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
VOTIS Subdermal Imaging Technologies Funding FAQs
What does VOTIS Subdermal Imaging Technologies do?
VOTIS Subdermal Imaging Technologies help diabetics keep their feet through early screening for peripheral vascular disease and related complications. Early screening can offer new treatment options and help reduce incidents of amputation. Their device is non-invasive and contact-free, not based on radiation, and functionally consistent with the guidelines of the AHA, the American Diabetes Association, and other leading medical organizations. It will reduce healthcare costs for hospitals, clinics, and insurers.
How much funding has VOTIS Subdermal Imaging Technologies raised?
VOTIS Subdermal Imaging Technologies has raised $2.5M across 1 round on record. The most recent is an undisclosed round of $2.5M announced in Jun 2021.
When did VOTIS Subdermal Imaging Technologies last raise funding?
VOTIS Subdermal Imaging Technologies' most recent funding round on record is an undisclosed round of $2.5M, announced in Jun 2021.
Who is the CEO of VOTIS Subdermal Imaging Technologies?
Merrill Weber is listed as CEO at VOTIS Subdermal Imaging Technologies.
Where is VOTIS Subdermal Imaging Technologies headquartered?
VOTIS Subdermal Imaging Technologies is based in Jerusalem, Yerushalayim, Israel.
How many employees does VOTIS Subdermal Imaging Technologies have?
VOTIS Subdermal Imaging Technologies is in the 1-10 employee band.
How does VOTIS Subdermal Imaging Technologies' funding compare to other Biotechnology startups?
VOTIS Subdermal Imaging Technologies' latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's VOTIS Subdermal Imaging Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VOTIS Subdermal Imaging Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.